A simple, highly sensitive, accurate, and low-cost electrochemical sensor was developed for the determination of over-the-counter painkiller, paracetamol (PC). The enhanced sensing capabilities of the developed sensor were fabricated by the single-step modification of disposable pencil graphite electrodes (PGEs) with the simultaneous electrochemical reduction in graphene oxide and antimony (II) salts. For this purpose, an electrochemically reduced graphene oxide–antimony nanoparticle (ERGO-SbNP) nanocomposite material was prepared by trapping metallic nanoparticles between individual graphene sheets in the modification of PGEs. Structural characterization by FTIR and Raman spectroscopy was employed to confirm the presence of oxygen functional groups and defects in the conjugated carbon-based structure of GO. Morphological differences between the modified PGEs were confirmed by HRTEM and HRSEM for the presence of nanoparticles. The modified electrodes were further electrochemically characterized using CV and EIS. The electrooxidation of PC on an ERGO-SbNPs-PGE was achieved by adsorptive stripping differential pulse voltametric analysis in 0.1 mol·L−1 phosphate buffer solution at pH = 7.0. The optimum current response was used to record a detection limit of 0.057 µmol·L−1 for PC. The electrochemical sensor was further used in real sample analysis for a commercially available pharmaceutical tablet (500 mg PC), for which the percentage recovery was between 99.4% and 100.8%.
For the first time, a novel mercaptosuccinic acid‐capped tungsten telluride quantum dot (MSA‐WTe3‐QD)‐based electrochemical aptasensor was designed for the determination of SARS‐CoV‐2 N‐protein in synthetic human serum, plasma and urine. The MSA‐WTe3‐QD which exhibited spherical morphology and an average diameter of 3.56 nm were synthesized through a bottom‐up approach. The aptasensor was prepared by firstly immobilizing MSA‐WTe3‐QD on a screen‐printed carbon electrode (SPCE) by using the 1‐ethyl‐3‐(3‐dimethylaminopropyl)carbodiimide/N‐hydroxysuccinimide (EDC/NHS) coupling chemistry. Thereafter, amine‐terminated 90‐mer ssDNA aptamer was deposited on the modified SPCE and left to cure to form the aptasensor. Using the chronocoulometry signal transduction technique, the aptasensor's calibration with N‐protein gave a linear range value of 1–9 pg.mL−1 and a limit of detection (LOD) value of 0.08 pg.mL−1. The LOD value of the aptasensor was 8 times lower than the LOD value of 0.71 pg.mL−1 obtained with a commercial N‐protein ELISA kit. When tested in simulated real samples the aptasensor recovery rates of 95–103.33 % were obtained. In the presence of various interferents, the aptasensor displayed good selectivity to N‐protein.
Tuberculosis (TB) continues to be a significant contributor to global death tolls among infectious diseases. It can be diagnosed using certain cytokines, such as interferon‐gamma (IFN‐γ). Interferon‐gamma is an essential component of the immune system's defense against pathogens which is known to be expressed in TB infection. This work involves the development of a quantum dot‐sensitized electrochemical aptasensor for IFN‐γ. The sensor system consists of gold disc electrode surface that was modified with novel L‐cysteine‐functionalized indium telluriselenide quantum dots (L‐cysteine‐InTeSe QD). Subsequently, the L‐cysteine‐InTeSe QDs are conjugated to an amine‐terminated IFN‐γ aptamer through a carbodiimide‐mediated amide bond formation. The electrochemical responses of the IFN‐γ aptasensor are studied by voltammetry. A linear calibration curve is generated for the concentration range studied (i.e., 10–21 pg mL−1 IFN‐γ), and a limit of detection of 0.312 pg mL−1 is obtained. The QD aptasensor is able to accurately detect IFN‐γ without interference from other substances. In a practical application using synthetic human serum, the QD aptasensor produced good detection recovery of 98–102%, highlighting its potential for diagnosing infectious diseases.